Our Focus Areas
We meticulously select cutting-edge technologies with strong commercial potential.
We do this, to meet global healthcare demands and strategically invest in their development to ensure their success.
Cube Labs at a glance
0
offices
0+M€
assets value
0+
universities in our network
0
startups
0
patents
0+
researchers in our network
Spearheading
democratization of healthcare
We aim to accelerate the democratization of the Life Science sector, making research, technologies, and tools more accessible to a wider audience.
This requires dismantling the barriers that restrict access to scientific information and fostering open innovation. By promoting the sharing of ideas and resources among institutions, companies, and individuals, we encourage new forms of collaboration and co-creation.
At Cube Labs, we are dedicated to driving meaningful change in healthcare, and we are excited about the future of innovation.
Achievements & Awards
Achievements & Awards
Latest News
IP
BIODIAPERS: CONCESSO BREVETTO EUROPEO PER UN ARTICOLO ASSORBENTE INNOVATIVO CON FUNZIONE DI SEPARAZIONE E ISOLAMENTO DELLE FECI
Roma, 14 gennaio 2026 – Cube Labs S.p.A. (“Cube Labs” o “Società”) – venture builder italiano nel settore delle tecnologie sanitarie quotato su Euronext Growth…...
IP
LIPOVEXA OTTIENE UN BREVETTO NEGLI STATI UNITI PER UNA NUOVA PIATTAFORMA TERAPEUTICA PER IL TRATTAMENTO DEI DISORDINI METABOLICI
Roma, 9 gennaio 2026 – Cube Labs S.p.A. (“Cube Labs” o “Società”) – venture builder italiano nel settore delle tecnologie sanitarie quotato su Euronext Growth…...
IP
ORPHA BIOTECH: ACCOLTA LA DOMANDA DI BREVETTO EUROPEO PER INIBITORI DELL’INTERAZIONE DEI RECETTORI uPAR/FPRs
Roma, 7 gennaio 2026 – Cube Labs S.p.A. (“Cube Labs” o “Società”) – venture builder italiano nel settore delle tecnologie sanitarie quotato su Euronext Growth…...